Wells Fargo Maintains Overweight on Agilon Health, Raises Price Target to $146
Wells Fargo analyst Stephen Baxter maintains Agilon Health (NYSE:AGL) with a Overweight and raises the price target from $141 to $146.
Read original at benzingaStocks · News reference
JP Morgan Maintains Underweight on Agilon Health, Raises Price Target to $85
JP Morgan analyst Lisa Gill maintains Agilon Health (NYSE:AGL) with a Underweight and raises the price target from $31 to $85.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 24, 2026, 1:57 PM
- Checked
- Aug 24, 2026, 1:57 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
This Best Buy Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Top Wall Street analysts upgraded various stocks, including BBY, BCE. See what other analysts think.
Read original at benzingaCitigroup Upgrades Agilon Health to Neutral, Raises Price Target to $115
Citigroup analyst Daniel Grosslight upgrades Agilon Health (NYSE:AGL) from Sell to Neutral and raises the price target from $105 to $115.
Read original at benzinga